Adenosine production in mesenchymal stromal cells in relation to their developmental status

No abstract is available for this paper.

• Publication year

  2020

• Venue

  HNO (Berlin. Print)

• Publication date

  2020-01-08

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00106-019-00805-zPMID 31915882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-β1 Production

  2019cited by this paper
• Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine

  2018cited by this paper
• The functional role of chondrogenic stem/progenitor cells: novel evidence for immunomodulatory properties and regenerative potential after cartilage injury.

  2018cited by this paper
• The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma

  2017cited by this paper
• Shockwaves Inhibit Chondrogenic Differentiation of Human Mesenchymal Stem Cells in Association with Adenosine and A2B Receptors

  2017cited by this paper
• The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets

  2017cited by this paper
• Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.

  2017cited by this paper
• Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism

  2016cited by this paper
• Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.

  2016cited by this paper
• Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg)

  2016cited by this paper
• Characterization of a migrative subpopulation of adult human nasoseptal chondrocytes with progenitor cell features and their potential for in vivo cartilage regeneration strategies

  2016cited by this paper
• Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.

  2016cited by this paper
• A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation

  2015cited by this paper
• Scaffold composition affects cytoskeleton organization, cell-matrix interaction and the cellular fate of human mesenchymal stem cells upon chondrogenic differentiation.

  2015cited by this paper
• Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

  2014cited by this paper
• The bidirectional tumor - mesenchymal stromal cell interaction promotes the progression of head and neck cancer

  2014cited by this paper
• Human CD4+CD39+ regulatory T cells produce adenosine upon co‐expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells

  2014cited by this paper
• CD39 and CD73 in immunity and inflammation.

  2013cited by this paper
• Mesenchymal stem cells from periapical lesions modulate differentiation and functional properties of monocyte‐derived dendritic cells

  2013cited by this paper
• Extracellular Purines Promote the Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells to the Osteogenic and Adipogenic Lineages

  2013cited by this paper
• CD73/5'-ecto-nucleotidase acts as a regulatory factor in osteo-/chondrogenic differentiation of mechanically stimulated mesenchymal stromal cells.

  2013cited by this paper
• Interaction between Adipose Tissue-Derived Mesenchymal Stem Cells and Regulatory T-Cells

  2013cited by this paper
• Prospective purification of a subpopulation of human synovial mesenchymal stem cells with enhanced chondro-osteogenic potency.

  2013cited by this paper
• Adenosine production by human B cells and B cell-mediated suppression of activated T cells.

  2013cited by this paper
• Growth Inhibitory Effect of Palatine Tonsil-derived Mesenchymal Stem Cells on Head and Neck Squamous Cell Carcinoma Cells

  2012cited by this paper
• Conditioned Medium from Adipose Tissue-Derived Mesenchymal Stem Cells Induces CD4+FOXP3+ Cells and Increases IL-10 Secretion

  2012cited by this paper
• Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes

  2011cited by this paper
• Immunosuppressive Properties of Mesenchymal Stem Cells

  2011cited by this paper
• Inhibition of T-Cell Proliferation by Murine Multipotent Mesenchymal Stromal Cells is Mediated by CD39 Expression and Adenosine Generation

  2011cited by this paper
• Tissue‐resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge

  2010cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

  2010cited by this paper
• Adenosine regulates CD8 T‐cell priming by inhibition of membrane‐proximal T‐cell receptor signalling

  2009cited by this paper
• Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

  2007cited by this paper
• Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors

  2005cited by this paper
• Immunophenotypic analysis of human articular chondrocytes: Changes in surface markers associated with cell expansion in monolayer culture

  2005cited by this paper
• Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors.

  2005cited by this paper
• CD 73 / 5 ’-ECTO-NUCLEOTIDASE ACTS AS A REGULATORY FACTOR IN OSTEO-/ CHONDROGENIC DIFFERENTIATION OF MECHANICALLY STIMULATED MESENCHYMAL STROMAL CELLS

  year unknowncited by this paper

• In vitro assays for investigating the immunomodulatory properties of human mesenchymal stromal cells.

  2026cites this paper
• Human placental mesenchymal stromal cells alleviate intestinal oxidative damage in mice with graft-versus-host disease via CD73/adenosine/PI3K/Akt/GSK-3β axis.

  2024cites this paper
• Metabolic heterogeneity in tumor microenvironment - A novel landmark for immunotherapy.

  2024cites this paper
• LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells

  2022cites this paper
• Cartilaginous Metabolomics Reveals the Biochemical-Niche Fate Control of Bone Marrow-Derived Stem Cells

  2022cites this paper
• Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism

  2022cites this paper
• CD73-Adenosinergic Axis Mediates the Protective Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Ischemic Renal Damage in a Rat Model of Donation after Circulatory Death

  2022cites this paper
• Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis

  2020cites this paper
• High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome

  2020cites this paper